2m 2m 2m 2m 2m 2m 2m
PLIANT THERAPEUT (PLRX)
NASDAQ
$1.16-$0.02 (-1.61%)
Price as of Jun 03, 2026 7:50 PM EDT- $78.0MMarket Cap
- -28.92%1-Year Change
- BiotechnologyIndustry
PLIANT THERAPEUT (PLRX)
$1.16-$0.02 (-1.61%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 N/A | 0 -100.00% | 1.6M -83.69% | 9.7M +27.91% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 -100.00% | 1.6M -83.69% | 9.7M +27.91% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -109.2M -35.53% | -169.3M +32.48% | -127.8M +31.84% | -96.9M +25.00% | |
Depreciation and Amortization Expense | 1.7M -20.19% | 2.1M +15.43% | 1.8M +0.99% | 1.8M +18.76% | |
Total Operating Expenses | 156.4M -31.52% | 228.4M +22.96% | 185.7M +35.68% | 136.9M +30.23% | |
Operating Profit | -156.4M -31.52% | -228.4M +24.01% | -184.1M +44.77% | -127.2M +30.41% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -1.3M N/A | 0 N/A | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -1.3M N/A | 0 N/A | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | 1.3M N/A | 0 N/A | |
Income before Taxes | -156.4M -31.52% | -228.4M +24.01% | -184.1M +49.32% | -123.3M +26.79% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -149.3M -28.99% | -210.3M +30.35% | -161.3M +30.83% | -123.3M +26.79% | |
Net Income from Continuing Operations Applicable to Common | -149.3M -28.99% | -210.3M +30.35% | -161.3M +30.83% | -123.3M +26.79% | |
Basic EPS and Net Income | -2.43 -29.97% | -3.47 +26.18% | -2.75 -6.46% | -2.94 +8.49% | |
Diluted EPS and Net Income | -2.43 -29.97% | -3.47 +26.18% | -2.75 -6.46% | -2.94 +8.49% | |
Basic Weighted Average Shares | 61.4M +1.37% | 60.5M +3.10% | 58.7M +39.75% | 42.0M +17.21% | |
Diluted Weighted Average Shares | 61.4M +1.37% | 60.5M +3.10% | 58.7M +39.75% | 42.0M +17.21% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 45.4M -36.16% | 71.2M +12.58% | 63.2M +87.72% | 33.7M -34.80% | |
Short-Term Investments | 145.5M -48.86% | 284.5M -33.98% | 431.0M +44.88% | 297.5M +99.76% | |
Cash and Cash Equivalents and Short-Term Investments | 190.9M -46.32% | 355.7M -28.03% | 494.2M +49.23% | 331.2M +65.10% | |
Total Current Assets | 196.4M -45.77% | 362.3M -28.34% | 505.5M +48.54% | 340.3M +62.49% | |
Accumulated Depreciation | 10.9M +0.57% | 10.8M +24.48% | 8.7M +26.91% | 6.8M +36.30% | |
Property and Plant and Equipment and Net | 2.9M -46.79% | 5.5M +54.89% | 3.6M -20.49% | 4.5M -2.61% | |
Total Long-Term Assets | 392,000 -9.89% | 435,000 +10.97% | 392,000 -0.51% | 394,000 -52.98% | |
Total Assets | 225.2M -43.26% | 396.9M -22.49% | 512.2M +46.07% | 350.6M +58.49% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.4M -86.00% | 10.0M +614.29% | 1.4M N/A | N/A N/A | |
Total Current Liabilities | 16.4M -50.73% | 33.2M +16.46% | 28.5M +19.28% | 23.9M +42.08% | |
Total Long-Term Debt | 0 -100.00% | 30.2M +200.49% | 10.1M +1.26% | 9.9M N/A | |
Total Long-Term Liabilities | 27.7M -53.63% | 59.6M +493.30% | 10.1M -24.73% | 13.4M N/A | |
Total Liabilities | 44.0M -52.60% | 92.9M +140.73% | 38.6M +3.51% | 37.3M +68.22% | |
Retained Earnings | -859.4M +21.03% | -710.1M +42.08% | -499.7M +47.67% | -338.4M +57.33% | |
Total Stockholders Equity | 181.2M -40.41% | 304.1M -35.79% | 473.6M +51.14% | 313.3M +57.41% | |
Total Shares Outstanding | 61.4M +0.97% | 60.9M +1.57% | 59.9M +22.43% | 48.9M +35.63% | |
Cash Flow | |||||
Cash from Operating Activities | -128.3M -17.47% | -155.5M +33.64% | -116.4M +22.96% | -94.6M +25.43% | |
Capital Expenditures | 374,000 -90.28% | 3.8M +317.81% | 921,000 -47.67% | 1.8M -9.88% | |
Cash from Investing Activities | 134.3M -4.31% | 140.3M +210.49% | -127.0M -15.44% | -150.2M -303.81% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -31.7M -237.12% | 23.1M -91.58% | 274.4M +20.96% | 226.9M +8,877.21% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | -11,654.75% +787.39% | -1,313.37% +1.96% | |
Return on Assets | -48.01% +3.76% | -46.27% +23.71% | -37.40% -13.29% | -43.13% +14.58% | |
Return on Equity | -61.55% +13.80% | -54.09% +31.90% | -41.00% -14.81% | -48.13% +19.30% | |
Revenue Growth | N/A N/A | -100.00% +19.49% | -83.69% -399.89% | 27.91% +134.08% | |
Current Ratio | 12.00 +10.07% | 10.91 -38.46% | 17.72 +24.53% | 14.23 +14.36% | |
Cash Ratio | 2.78 +29.58% | 2.14 -3.33% | 2.22 +57.38% | 1.41 -54.11% | |
Debt-to-Equity Ratio | 0.008 -94.18% | 0.13 +446.28% | 0.02 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.006 -93.88% | 0.10 +352.23% | 0.02 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow